£1.1M
The pre-seed round was led by QUBIS Innovation Fund and will support clinical trial preparations and engineering hires.
TD
Transdermal Diagnostics
Transdermal Diagnostics develops a needle-free platform for continuous blood sugar monitoring.
Bristol, UK
£1.1MTotal raised
Transdermal Diagnostics is a Bristol-based medical technology spin-out developing a needle-free platform for continuous blood sugar monitoring. The firm uses miniaturised biosensors on wearable patches to track health biomarkers without puncturing the skin.
Categories
Founders
LL
Luca Lipani
Founder and CEO
AI
Adelina Ilie
Chief Scientific Officer
RG
Richard Guy
Company director